BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Edaravone

An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.

298+ PubMed studies analyzed · 19 RCTs · Evidence Score: 46.8

Research Domains

Edaravone has been studied across 22 research domains including 🧠 Neuroprotection, 🔬 Inflammation, 🧘 Stress & Anxiety, 🔬 Oncology, ❤️ Cardiovascular. The primary research focus is 🧠 Neuroprotection with 33% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Edaravone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Demeclocycline
10 shared targets
Piperonyl
10 shared targets
Vitamin
16 shared targets
Nitrofurazone
10 shared targets
Beclomethasone
10 shared targets
sulindac
9 shared targets
Methoxsalen
9 shared targets
Lumefantrine
9 shared targets
Ezetimibe
11 shared targets
Flutamide
12 shared targets
Loading evidence profile...

This evidence profile for Edaravone is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.